Breaking News Instant updates and real-time market news.

BBU

Brookfield Business Partners

$38.83

(0.00%)

, EYE

National Vision

$33.18

0.01 (0.03%)

08:30
04/13/18
04/13
08:30
04/13/18
08:30

Thirteen new option listings and ten option delistings on April 13th

New option listings for April 13th include iPath Bloomberg Cotton Subindex Total Return ETN (BALTF), Brookfield Business Partners (BBU), iPath Bloomberg Livestock Subindex Total Return ETN (COWTF), NTT DOCOMO Inc (ADR) (DCMYY), National Vision Holdings Inc (EYE), Innovate Biopharmaceuticals Inc (INNT), iPath MCSI India Index ETN (INPTF), iPath Bloomberg Copper Subindex Total Return ETN (JJCTF), iPath Bloomberg Grains Subindex Total Return ETN (JJGTF), iPath Bloomberg Coffee Subindex Total Return ETN (JJOFF), iPath S&P GSCI Crude Oil Total Return (OILNF), iPath Bloomberg Sugar Subindex Total Return ETN (SGGFF), and Tandem Diabetes (TNDM). Option delistings effective April 13th include iPath Bloomberg Cotton Subindex Total Return ETN (BAL), iPath Bloomberg Livestock Subindex Total Return ETN (COW), NTT DOCOMO Inc (ADS) (DCM), iPath MCSI India Index ETN (INP), iPath Bloomberg Copper Subindex Total Return ETN (JJC), iPath Bloomberg Grains Subindex Total Return ETN (JJG), iPath Bloomberg Coffee Subindex Total Return ETN (JO), iPath S&P GSCI Crude Oil Total Return (OIL), Ply Gem Holdings Inc (PGEM), and iPath Bloomberg Sugar Subindex Total Return ETN (SGG).

BBU

Brookfield Business Partners

$38.83

(0.00%)

EYE

National Vision

$33.18

0.01 (0.03%)

INNT

Innovate Biopharmaceuticals

$27.96

3.35 (13.61%)

TNDM

TNDM

BAL

Balanced Care

$0.00

(0.00%)

DCM

NTT DoCoMo

$0.00

(0.00%)

OIL

Triton Energy

$0.00

(0.00%)

PGEM

Taken private

$21.65

(0.00%)

SGG

iPath Dow Jones-UBS Sugar Subindex

$0.00

(0.00%)

  • 26

    Apr

  • 07

    May

  • 08

    May

BBU Brookfield Business Partners
$38.83

(0.00%)

03/16/18
RBCM
03/16/18
UPGRADE
RBCM
Outperform
Brookfield Business upgraded to Outperform from Sector Perform at RBC Capital
01/18/18
01/18/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Caterpillar (CAT) initiated with a Buy at Berenberg. 2. Rosehill Resources (ROSE) initiated with an Outperform at Northland. 3. Arena Pharmaceuticals (ARNA) initiated with an Outperform at Credit Suisse. 4. Electronic Arts (EA) was initiated with an Outperform at Bernstein, while Activision Blizzard (ATVI) was initiated with a Market Perform. 5. Brookfield Business Partners (BBU) initiated with a Sector Perform at RBC Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
01/18/18
RBCM
01/18/18
INITIATION
Target $41
RBCM
Sector Perform
Brookfield Business Partners initiated with a Sector Perform at RBC Capital
RBC Capital analyst Geoffrey Kwan initiated Brookfield Business Partners with a Sector Perform rating and a price target of $41. Kwan says the company offers a "strong investment track record and a diverse collection of investments in the Business Services, Industrials, Energy and Construction sectors". The analyst also sees units as fairly valued over the 12-month horizon, trading at a slight premium relative to his estimated NAV.
01/05/18
FBCO
01/05/18
NO CHANGE
Target $42
FBCO
Outperform
Brookfield Business Partners price target raised to $42 from $34 at Credit Suisse
Credit Suisse analyst Nick Stogdill noted that Brookfield Business Partners (BBU) and its institutional partners will acquire 100% of Westinghouse Electric from Toshiba (TOSBF) for $4.6B, which he views as positive news from both a strategic and financial perspective. The analyst, who increased his 2018 EPS estimate 11% to $3.15 to reflect the deal, keeps an Outperform rating on Brookfield Business Partners and raised his price target on the stock to $42.
EYE National Vision
$33.18

0.01 (0.03%)

11/20/17
GSCO
11/20/17
INITIATION
Target $30
GSCO
Neutral
National Vision initiated with a Neutral at Goldman Sachs
Goldman analyst Matthew Fassler initiated National Vision with a Neutral and $30 price target saying valuation reflects the company's appealing growth profile.
11/20/17
11/20/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Innoviva (INVA) initiated with a Hold at Deutsche Bank. 2. National Vision (EYE) was initiated with an Overweight at Morgan Stanley, an Outperform at Wells Fargo, a Buy at Jefferies and Citi, as well as a Neutral at Goldman Sachs, UBS, and BofA/Merrill. 3. Ablynx (ABLX) was initiated with an Overweight at JPMorgan, an Outperform at Baird, and a Buy at Ladenburg. 4. Blue Apron (APRN) initiated with a Sector Weight at KeyBanc. 5. BP Midstream (BPMP) was initiated with an Overweight at JPMorgan, a Buy at UBS and Citi, an Equal Weight at Morgan Stanley and Barclays, as well as a Neutral at Goldman Sachs. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/21/17
GUGG
11/21/17
INITIATION
GUGG
Buy
National Vision initiated with a Buy at Guggenheim
01/18/18
WELS
01/18/18
NO CHANGE
Target $45
WELS
Outperform
National Vision price target raised to $45 from $37 at Wells Fargo
Wells Fargo analyst Zachary Fadem raised his price target for National Vision to $45 from $37 to reflect tax reform. The analyst reiterates an Outperform rating on the shares.
INNT Innovate Biopharmaceuticals
$27.96

3.35 (13.61%)

TNDM TNDM

04/10/18
PIPR
04/10/18
NO CHANGE
PIPR
Neutral
Too early to call Tandem Diabetes revenue beat a trend, says Piper Jaffray
Piper Jaffray analyst JP McKim noted that Tandem Diabetes announced preliminary Q1 revenue that beat his estimate of $24.8M and the consensus view near $25M. McKim, who thinks the company "clearly benefited" from the exit of Animas from the U.S. market, is incrementally more positive on Tandem but awaits more evidence of an accelerating growth trend before changing his Neutral rating on the stock.
03/28/18
COWN
03/28/18
UPGRADE
Target $7
COWN
Outperform
Tandem Diabetes upgraded to Outperform on market share gains at Cowen
As reported previously, Cowen analyst Doug Schenkel upgraded Tandem Diabetes (TNDM) to Outperform from Market Perform. The analyst cited his recent diabetes devices survey, which suggested the company is picking up market share from Animas' market exit and he sees excitement about its integration with Dexcom (DXCM). Schenkel raised his price target to $7 from $5 on Tandem Diabetes shares.
03/28/18
COWN
03/28/18
UPGRADE
Target $7
COWN
Outperform
Tandem Diabetes upgraded to Outperform from Market Perform at Cowen
Cowen analyst Doug Schenkel upgraded Tandem Diabetes to Outperform and raised his price target for the shares to $7 from $5.
03/23/18
03/23/18
UPGRADE
Target $7

Outperform
Tandem Diabetes upgraded to Outperform at Baird
As previously reported, Baird upgraded Tandem Diabetes to Outperform from Neutral and raised its price target to $7 from $3. Analyst Jeff Johnson has gone from thinking that Tandem may not survive to believing management may have the most compelling HCL system in diabetes by mid-2019. Johnson's newfound conviction in the product pipeline comes from management's prudent move of its t:slim X2 Insulin Pump system to a PMA versus 510(k) platform two years ago, that helped establish important relationships with FDA's PMA division. Further, the analyst believes Tandem's timeline for potential approval of its Control IQ system in 1H19 looks more reasonable than we previously realized, leading to a potential launch by mid-2019, and a head start over Medtronic's (MDT) 670G system and Insulet's (PODD) advanced HCL system.
BAL Balanced Care
$0.00

(0.00%)

DCM NTT DoCoMo
$0.00

(0.00%)

01/26/18
DBAB
01/26/18
UPGRADE
DBAB
Hold
NTT DoCoMo upgraded to Hold from Sell at Deutsche Bank
01/21/18
HSBC
01/21/18
DOWNGRADE
HSBC
Hold
NTT DoCoMo downgraded to Hold from Buy at HSBC
12/14/17
DBAB
12/14/17
DOWNGRADE
DBAB
Sell
NTT DoCoMo downgraded to Sell from Hold at Deutsche Bank
Deutsche Bank downgraded NTT DoCoMo to Sell with a price target of 2,550 yen.
04/11/18
UBSW
04/11/18
INITIATION
UBSW
Sell
NTT DoCoMo initiated with a Sell at UBS
UBS analyst Kei Takahashi started NTT DoCoMo with a Sell rating.
OIL Triton Energy
$0.00

(0.00%)

PGEM Taken private
$21.65

(0.00%)

02/21/18
RBCM
02/21/18
DOWNGRADE
RBCM
Sector Perform
Ply Gem downgraded to Sector Perform from Outperform at RBC Capital
Ply Gem (PGEM) is being acquired by Clayton, Dubilier & Rice for $21.64 per share in cash.
SGG iPath Dow Jones-UBS Sugar Subindex
$0.00

(0.00%)

TODAY'S FREE FLY STORIES

PFE

Pfizer

$37.33

-0.03 (-0.08%)

16:26
07/20/18
07/20
16:26
07/20/18
16:26
Hot Stocks
FDA approves Pfizer's Biosimilar NIVESTYM for all indications »

Pfizer announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 10

    Sep

JCP

J.C. Penney

$2.50

-0.065 (-2.53%)

16:23
07/20/18
07/20
16:23
07/20/18
16:23
Hot Stocks
J.C. Penney chief customer officer McFarland to leave company »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
07/20/18
07/20
16:20
07/20/18
16:20
Options
Closing CBOE SPX and VIX Index summary for July 20th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASFI

Asta Funding

$3.15

-0.1 (-3.08%)

16:18
07/20/18
07/20
16:18
07/20/18
16:18
Hot Stocks
Asta Funding receives Nasdaq non-compliance letter »

Asta Funding announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
07/20/18
07/20
16:17
07/20/18
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

16:16
07/20/18
07/20
16:16
07/20/18
16:16
Technical Analysis
NYSE market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

16:15
07/20/18
07/20
16:15
07/20/18
16:15
Periodicals
Disney fires 'Guardians' director after controversial tweets, THR says »

Disney has fired James…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

MSFT

Microsoft

, GE

General Electric

16:15
07/20/18
07/20
16:15
07/20/18
16:15
General news
Fly Intel: Wall Street's top stories for Friday »

Stocks began the day…

MSFT

Microsoft

GE

General Electric

HON

Honeywell

PAH

Platform Specialty Products

GSK

GlaxoSmithKline

PTCT

PTC Therapeutics

LLNW

Limelight Networks

VFC

VF Corp.

SKX

Skechers

STT

State Street

SWKS

Skyworks

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

  • 20

    Jul

  • 20

    Jul

  • 20

    Jul

  • 20

    Jul

  • 25

    Jul

  • 08

    Aug

  • 08

    Aug

  • 14

    Aug

  • 04

    Sep

MYL

Mylan

$35.57

-0.08 (-0.22%)

, AGN

Allergan

$171.85

-1.53 (-0.88%)

16:12
07/20/18
07/20
16:12
07/20/18
16:12
Hot Stocks
PTAB rules in favor of Mylan to allow Restasis challenge to proceed »

Mylan (MYL) announced…

MYL

Mylan

$35.57

-0.08 (-0.22%)

AGN

Allergan

$171.85

-1.53 (-0.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 13

    Nov

CEI

Camber Energy

$0.45

-0.0236 (-5.03%)

16:07
07/20/18
07/20
16:07
07/20/18
16:07
Hot Stocks
Breaking Hot Stocks news story on Camber Energy  »

Discover Growth Fund…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JONE

Jones Energy

$0.38

-0.0117 (-3.02%)

16:06
07/20/18
07/20
16:06
07/20/18
16:06
Hot Stocks
Jones Energy names Carl Giesler, Jr. CEO »

Jones Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PYPL

PayPal

$87.26

-0.14 (-0.16%)

16:01
07/20/18
07/20
16:01
07/20/18
16:01
Periodicals
Third Point looking into new PayPal investment, Dealreporter says »

Third Point is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 15

    Aug

  • 16

    Aug

BLK

BlackRock

$502.28

-2.15 (-0.43%)

16:01
07/20/18
07/20
16:01
07/20/18
16:01
Hot Stocks
BlackRock CEO Fink discloses sale of $10.1M in stock »

BlackRock CEO Laurence…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VFC

VF Corp.

$93.33

4.12 (4.62%)

15:50
07/20/18
07/20
15:50
07/20/18
15:50
Options
Defensive option play in VF Corp as shares spike on earnings »

Defensive option play in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

BAC

Bank of America

$30.06

0.4 (1.35%)

15:40
07/20/18
07/20
15:40
07/20/18
15:40
Options
Biggest option block of the day is in Bank of America »

Biggest option block of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GSK

GlaxoSmithKline

$41.82

1.125 (2.76%)

15:30
07/20/18
07/20
15:30
07/20/18
15:30
Periodicals
GSK tells Bloomberg three business structure offers 'significant opportunities' »

Glaxosmithkline told…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

GE

General Electric

$13.14

-0.59 (-4.30%)

15:30
07/20/18
07/20
15:30
07/20/18
15:30
Options
Heavy trading in GE options as shares face renewed selling pressure »

Heavy trading in GE…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

WSM

Williams-Sonoma

$61.73

-1.01 (-1.61%)

15:25
07/20/18
07/20
15:25
07/20/18
15:25
Options
Williams Sonoma call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMT

Lockheed Martin

$322.13

2.46 (0.77%)

15:24
07/20/18
07/20
15:24
07/20/18
15:24
Periodicals
Lockheed Martin's F-35 to play bigger role in Europe defense, Reuters says »

U.S. and European defense…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

IWM

iShares Trust Russell 2000 Index Fund

$168.82

-0.32 (-0.19%)

, RUT

Russell 2000 Index

$0.00

(0.00%)

15:20
07/20/18
07/20
15:20
07/20/18
15:20
Technical Analysis
On The Fly: Weekly technical notes for Russell 2000 »

The Russell 2000 Index…

IWM

iShares Trust Russell 2000 Index Fund

$168.82

-0.32 (-0.19%)

RUT

Russell 2000 Index

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:20
07/20/18
07/20
15:20
07/20/18
15:20
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

TCF

TCF Financial

$25.35

-0.05 (-0.20%)

15:18
07/20/18
07/20
15:18
07/20/18
15:18
Hot Stocks
TCF Bank enters BFCP settlement with CFPB to resolve litigation »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
07/20/18
07/20
15:17
07/20/18
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
07/20/18
07/20
15:16
07/20/18
15:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$279.90

-0.05 (-0.02%)

15:09
07/20/18
07/20
15:09
07/20/18
15:09
Technical Analysis
On The Fly: Weekly technical notes for S&P 500 »

The S&P 500 (SPX), at…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$279.90

-0.05 (-0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.